Lidak Pharm. [LDAKA] Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA]

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: henry jakala who wrote (324)	8/8/1997 8:03:00 AM
From: Henry Volquardsen	of 1115

Henry, you got me worried there for a second. I went back and checked and the Nov 27 story has Lidak reaquiring the international rights. Bristol-Myers retained the rights for the US, Canada and Mexico. The rights that Lidak reaquired were for China, South and Central America, Australia, India and some portions of Asia. This agreement only covered the topical treatment of oral herpes. BMY retained a right of first offer for the treatment of genital herpes and other potential topical and systemic uses. FWIW the pr quote from Katz that went with this announcement was "Lidak is benefitting greatly from its continuing relationship with Bristol-Myers Squibb, which we believe is the strongest possible partner for marketing LIDAKOL in North America." This is the most recent comment I have seen on the licensing of LIDAKOL. So if there was a subsequent announcement I missed it.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next